VIMAC Ventures LLC is a Boston-based venture capital firm that invests in emerging growth companies geographically located in the northeastern U.
VIMAC Milestone Medica Fund is the firm's life sciences fund originally co-sponsored with RBC, BTG, and VIMAC.
Milestone Medica Fund (VMM) is a life sciences venture capital fund providing equity financing to entrepreneurial companies.
We look forward to working with VIMAC
Ventures and Commons Capital to build a company that we believe will have a significant impact on women's health.
Based in Boston, VIMAC
Ventures deploys capital in early-stage companies located in the eastern U.
The continued strong support of BDC Venture Capital and the commitment of VIMAC Milestone Medica at this stage of the company's development is recognition of the tremendous potential of AngioChem's technology" stated Dr Robert Dugre, president and CEO of AngioChem.
Sena Biswas, Managing Director of VIMAC will join the AngioChem board of directors.
VIMAC Milestone Medica Fund is an early stage life sciences fund co-sponsored by VIMAC Ventures LLC, RBC Technology Ventures, and BTG.
Nakina Systems is a shining light in an industry that is undergoing fundamental change," explained Mark Robinson, Director with VIMAC, a Boston-based VC with extensive investments in start-ups across the Eastern U.
Pat DiPietro, Managing Partner at VenGrowth, added: "We welcome both VIMAC and EDC to the family of investment companies lending their strategic support to Nakina.
Attracting VIMAC and EDC to our existing group of investment partners is a major milestone for Nakina," said Dave Vicary, President & CEO of Nakina.
The Series A round was co-led by The Aurora Funds, Quaker BioVentures, and VIMAC
Milestone Medica Fund.